English

Entia Biosciences, Inc.

EDGAR

Annual report (10-K) · filed 2017-05-19

45 filing records in this dataset, filed from 2007-12-11 to 2017-05-19. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

46 thousand USD

2016 Q4 · USD

Exact inputs and evidence

Revenue: 265466 USD Source
Revenue: 219480 USD Source

Operating margin

-838.59%

2016 Q4 · %

Exact inputs and evidence

Operating Income: -1310348 USD Source
Operating Income: -924713 USD Source
Revenue: 265466 USD Source
Revenue: 219480 USD Source

Operating cash flow

-440 thousand USD

2016 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -715098 USD Source
Operating Cash Flow: -275142 USD Source

Free cash flow

-440 thousand USD

2016 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -715098 USD Source
Operating Cash Flow: -275142 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 76.1 thousand USD 2016-12-31 Source
Exact value

76050 USD
Long-term debt including current maturities: Not available
Shares outstanding: 28.1 million shares 2016-12-31 Source
Exact value

28149777 shares

Reported share-count change

0.15% · 42.4 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

28107337 shares · 2015-12-31· Source
28149777 shares · 2016-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

265 thousand USD

2016-01-01 – 2016-12-31

Exact inputs and evidence

Revenue: 79200 USD · 2016-01-01 – 2016-03-31 Source
Revenue: 98425 USD · 2016-04-01 – 2016-06-30 Source
Revenue: 41855 USD · 2016-07-01 – 2016-09-30 Source
Revenue: 265466 USD · 2016-01-01 – 2016-12-31 Source
Revenue: 219480 USD · 2016-01-01 – 2016-09-30 Source

Net income

-1.4 million USD

2016-01-01 – 2016-12-31

Exact inputs and evidence

Net income: -272592 USD · 2016-01-01 – 2016-03-31 Source
Net income: -401631 USD · 2016-04-01 – 2016-06-30 Source
Net income: -288776 USD · 2016-07-01 – 2016-09-30 Source
Net income: -1395782 USD · 2016-01-01 – 2016-12-31 Source
Net income: -963005 USD · 2016-01-01 – 2016-09-30 Source

Operating cash flow

-715 thousand USD

2016-01-01 – 2016-12-31

Exact inputs and evidence

Operating cash flow: -99193 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -201528 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -99193 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -275142 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -201528 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -715098 USD · 2016-01-01 – 2016-12-31 Source
Operating cash flow: -275142 USD · 2016-01-01 – 2016-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-05-19.

Financial data available through: 2016-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2016-12-31
Operating income: 8 of 11 periods available· newest 2016-12-31
Net income: 9 of 11 periods available· newest 2016-12-31
Operating cash flow: 9 of 11 periods available· newest 2016-12-31
Capital expenditure: 7 of 11 periods available· newest 2016-12-31
Total assets: 8 of 11 periods available· newest 2016-12-31
Total liabilities: 8 of 11 periods available· newest 2016-12-31
Current assets: 8 of 11 periods available· newest 2016-12-31
Current liabilities: 8 of 11 periods available· newest 2016-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2016-12-31
long term debt: No compatible figures in this window
Shares outstanding: 4 of 11 periods available· newest 2016-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-23.5%

Prior period

USD 346,910

2015-01-01 – 2015-12-31
Current period

USD 265,466

2016-01-01 – 2016-12-31

Exact inputs and evidence

265466 − 346910 = -81444 USD

346910 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
265466 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Entia Biosciences, Inc. · 2016-12-31 Entia Biosciences, Inc. (edgar:1408299) Year-over-year change in Revenue: -81444 USD Concept: fundies:Revenue Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 265466 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#152286 Filing: 000118518517001225 Input fundies:Revenue: 346910 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#152399 Filing: 000118518517001225
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 864,268

Prior period

−USD 2.26 million

2015-01-01 – 2015-12-31
Current period

−USD 1.4 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

-1395782 − -2260050 = 864268 USD

-2260050 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-1395782 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Entia Biosciences, Inc. · 2016-12-31 Entia Biosciences, Inc. (edgar:1408299) Year-over-year change in Net income: 864268 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1395782 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#157235 Filing: 000118518517001225 Input fundies:NetIncome: -2260050 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#157360 Filing: 000118518517001225
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 178,533

Prior period

−USD 536,565

2015-01-01 – 2015-12-31
Current period

−USD 715,098

2016-01-01 – 2016-12-31

Exact inputs and evidence

-715098 − -536565 = -178533 USD

-536565 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-715098 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Entia Biosciences, Inc. · 2016-12-31 Entia Biosciences, Inc. (edgar:1408299) Year-over-year change in Operating cash flow: -178533 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -715098 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177080 Filing: 000118518517001225 Input fundies:OperatingCashFlow: -536565 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177262 Filing: 000118518517001225
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 8,051

2015-01-01 – 2015-12-31
Current period

USD 0

2016-01-01 – 2016-12-31

Exact inputs and evidence

0 − 8051 = -8051 USD

8051 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
0 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Entia Biosciences, Inc. · 2016-12-31 Entia Biosciences, Inc. (edgar:1408299) Year-over-year change in Capital expenditure: -8051 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177444 Filing: 000118518517001225 Input fundies:CapitalExpenditure: 8051 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177620 Filing: 000118518517001225
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2016-01-01 – 2016-12-31

Revenue USD 265,466 100% of revenue
Cost of revenue USD 91,499 34% of revenue
Operating expenses USD 1.48 million 559% of revenue
Operating income −USD 1.31 million −494% of revenue
Tax, interest and other Derived USD 85,434 32% of revenue
Net income −USD 1.4 million −526% of revenue

Cash

Operating cash flow −USD 715,098 −269% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived −USD 715,098 −269% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Operating loss: operating costs were 1,477% of revenue.
2010 Operating loss: operating costs were 365% of revenue.
2011 Operating loss: operating costs were 465% of revenue.
2012 Operating loss: operating costs were 393% of revenue.
2013 Operating loss: operating costs were 1,044% of revenue.
2014 Operating loss: operating costs were 374% of revenue.
2015 Operating loss: operating costs were 684% of revenue.
2016 Operating loss: operating costs were 594% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	67608	998797 Derived	-931189	-4400 Derived	-926789	-575370 Derived	Source 2009-01-01 – 2009-12-31: 67608 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -931189 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -926789 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -554658 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 20712 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	382051	1393306 Derived	-1011255	255060 Derived	-1266315	-554737 Derived	Source 2010-01-01 – 2010-12-31: 382051 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -1011255 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -1266315 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -522930 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 31807 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	403338	1876809 Derived	-1473471	255632 Derived	-1729103	Unavailable	Source 2011-01-01 – 2011-12-31: 403338 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -1473471 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -1729103 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -208744 USD Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	369273	1449957 Derived	-1080684	183464 Derived	-1264148	Unavailable	Source 2012-01-01 – 2012-12-31: 369273 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -1080684 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -1264148 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -314595 USD Inspect Operating Cash Flow Open source
2013 2013-01-01 – 2013-12-31	314746	3284766 Derived	-2970020	134807 Derived	-3104827	-819281 Derived	Source 2013-01-01 – 2013-12-31: 314746 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -2970020 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -3104827 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -766733 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 52548 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	656342	2454356 Derived	-1798014	498577 Derived	-2296591	-684891 Derived	Source 2014-01-01 – 2014-12-31: 656342 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -1798014 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -2296591 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -680284 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 4607 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	346910	2372866 Derived	-2025956	234094 Derived	-2260050	-544616 Derived	Source 2015-01-01 – 2015-12-31: 346910 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -2025956 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -2260050 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -536565 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 8051 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	265466	1575814 Derived	-1310348	85434 Derived	-1395782	-715098 Derived	Source 2016-01-01 – 2016-12-31: 265466 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -1310348 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -1395782 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -715098 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 265.5K 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Revenue	67608	Revenue: 67608 Open source
20102010-12-31	Revenue	382051	Revenue: 382051 Open source
20112011-12-31	Revenue	403338	Revenue: 403338 Open source
20122012-12-31	Revenue	369273	Revenue: 369273 Open source
20132013-12-31	Revenue	314746	Revenue: 314746 Open source
20142014-12-31	Revenue	656342	Revenue: 656342 Open source
20152015-12-31	Revenue	346910	Revenue: 346910 Open source
20162016-12-31	Revenue	265466	Revenue: 265466 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-23.5% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 67608 Open source
20102010-12-31	Year over year	465.1%	Revenue: 382051 Open source Revenue: 67608 Open source
20112011-12-31	Year over year	5.6%	Revenue: 403338 Open source Revenue: 382051 Open source
20122012-12-31	Year over year	-8.4%	Revenue: 369273 Open source Revenue: 403338 Open source
20132013-12-31	Year over year	-14.8%	Revenue: 314746 Open source Revenue: 369273 Open source
20142014-12-31	Year over year	108.5%	Revenue: 656342 Open source Revenue: 314746 Open source
20152015-12-31	Year over year	-47.1%	Revenue: 346910 Open source Revenue: 656342 Open source
20162016-12-31	Year over year	-23.5%	Revenue: 265466 Open source Revenue: 346910 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -493.6% 2016

Net margin -525.8% 2016

Free cash flow margin -269.4% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	-1,377.3%	Operating Income: -931189 Open source Revenue: 67608 Open source
20102010-12-31	Operating margin	-264.7%	Operating Income: -1011255 Open source Revenue: 382051 Open source
20112011-12-31	Operating margin	-365.3%	Operating Income: -1473471 Open source Revenue: 403338 Open source
20122012-12-31	Operating margin	-292.7%	Operating Income: -1080684 Open source Revenue: 369273 Open source
20132013-12-31	Operating margin	-943.6%	Operating Income: -2970020 Open source Revenue: 314746 Open source
20142014-12-31	Operating margin	-273.9%	Operating Income: -1798014 Open source Revenue: 656342 Open source
20152015-12-31	Operating margin	-584%	Operating Income: -2025956 Open source Revenue: 346910 Open source
20162016-12-31	Operating margin	-493.6%	Operating Income: -1310348 Open source Revenue: 265466 Open source
20092009-12-31	Net margin	-1,370.8%	Net Income: -926789 Open source Revenue: 67608 Open source
20102010-12-31	Net margin	-331.5%	Net Income: -1266315 Open source Revenue: 382051 Open source
20112011-12-31	Net margin	-428.7%	Net Income: -1729103 Open source Revenue: 403338 Open source
20122012-12-31	Net margin	-342.3%	Net Income: -1264148 Open source Revenue: 369273 Open source
20132013-12-31	Net margin	-986.5%	Net Income: -3104827 Open source Revenue: 314746 Open source
20142014-12-31	Net margin	-349.9%	Net Income: -2296591 Open source Revenue: 656342 Open source
20152015-12-31	Net margin	-651.5%	Net Income: -2260050 Open source Revenue: 346910 Open source
20162016-12-31	Net margin	-525.8%	Net Income: -1395782 Open source Revenue: 265466 Open source
20092009-12-31	Free cash flow margin	-851%	Revenue: 67608 Open source Operating Cash Flow: -554658 Open source Capital Expenditure: 20712 Open source
20102010-12-31	Free cash flow margin	-145.2%	Revenue: 382051 Open source Operating Cash Flow: -522930 Open source Capital Expenditure: 31807 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 403338 Open source Operating Cash Flow: -208744 Open source
20122012-12-31	Free cash flow margin	Not reported	Revenue: 369273 Open source Operating Cash Flow: -314595 Open source
20132013-12-31	Free cash flow margin	-260.3%	Revenue: 314746 Open source Operating Cash Flow: -766733 Open source Capital Expenditure: 52548 Open source
20142014-12-31	Free cash flow margin	-104.3%	Revenue: 656342 Open source Operating Cash Flow: -680284 Open source Capital Expenditure: 4607 Open source
20152015-12-31	Free cash flow margin	-157%	Revenue: 346910 Open source Operating Cash Flow: -536565 Open source Capital Expenditure: 8051 Open source
20162016-12-31	Free cash flow margin	-269.4%	Revenue: 265466 Open source Operating Cash Flow: -715098 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -715.1K 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Operating cash flow	-554658	Operating Cash Flow: -554658 Open source
20102010-12-31	Operating cash flow	-522930	Operating Cash Flow: -522930 Open source
20112011-12-31	Operating cash flow	-208744	Operating Cash Flow: -208744 Open source
20122012-12-31	Operating cash flow	-314595	Operating Cash Flow: -314595 Open source
20132013-12-31	Operating cash flow	-766733	Operating Cash Flow: -766733 Open source
20142014-12-31	Operating cash flow	-680284	Operating Cash Flow: -680284 Open source
20152015-12-31	Operating cash flow	-536565	Operating Cash Flow: -536565 Open source
20162016-12-31	Operating cash flow	-715098	Operating Cash Flow: -715098 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -715.1K 2016

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20092009-12-31	Free cash flow	-575370	Operating Cash Flow: -554658 Open source Capital Expenditure: 20712 Open source
20102010-12-31	Free cash flow	-554737	Operating Cash Flow: -522930 Open source Capital Expenditure: 31807 Open source
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -208744 Open source
20122012-12-31	Free cash flow	Unavailable	Operating Cash Flow: -314595 Open source
20132013-12-31	Free cash flow	-819281	Operating Cash Flow: -766733 Open source Capital Expenditure: 52548 Open source
20142014-12-31	Free cash flow	-684891	Operating Cash Flow: -680284 Open source Capital Expenditure: 4607 Open source
20152015-12-31	Free cash flow	-544616	Operating Cash Flow: -536565 Open source Capital Expenditure: 8051 Open source
20162016-12-31	Free cash flow	-715098	Operating Cash Flow: -715098 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

547.8% 2016

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Liabilities / assets	27.4%	Total Liabilities: 138050 Open source Total Assets: 503145 Open source
20102010-12-31	Liabilities / assets	169%	Total Liabilities: 747695 Open source Total Assets: 442542 Open source
20112011-12-31	Liabilities / assets	164.2%	Total Liabilities: 664652 Open source Total Assets: 404900 Open source
20122012-12-31	Liabilities / assets	240%	Total Liabilities: 1111262 Open source Total Assets: 462969 Open source
20132013-12-31	Liabilities / assets	250.5%	Total Liabilities: 1580681 Open source Total Assets: 631094 Open source
20142014-12-31	Liabilities / assets	113.4%	Total Liabilities: 987244 Open source Total Assets: 870708 Open source
20152015-12-31	Liabilities / assets	276.4%	Total Liabilities: 1239794 Open source Total Assets: 448606 Open source
20162016-12-31	Liabilities / assets	547.8%	Total Liabilities: 2405702 Open source Total Assets: 439141 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.11× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Current assets / current liabilities	3.16×	Current Assets: 436502 Open source Current Liabilities: 138050 Open source
20102010-12-31	Current assets / current liabilities	0.58×	Current Assets: 317253 Open source Current Liabilities: 550745 Open source
20112011-12-31	Current assets / current liabilities	0.43×	Current Assets: 258381 Open source Current Liabilities: 599652 Open source
20122012-12-31	Current assets / current liabilities	0.22×	Current Assets: 244236 Open source Current Liabilities: 1109157 Open source
20132013-12-31	Current assets / current liabilities	0.14×	Current Assets: 225451 Open source Current Liabilities: 1580681 Open source
20142014-12-31	Current assets / current liabilities	0.44×	Current Assets: 437394 Open source Current Liabilities: 987244 Open source
20152015-12-31	Current assets / current liabilities	0.1×	Current Assets: 128336 Open source Current Liabilities: 1239794 Open source
20162016-12-31	Current assets / current liabilities	0.11×	Current Assets: 234347 Open source Current Liabilities: 2105624 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2008 2008-01-01 – 2008-12-31	−USD 121,135 Exact value Exact value: -121135 USD 2008-01-01 – 2008-12-31: -121135 USD Inspect Net Income Open source Share or cite Citation for Net Income · Entia Biosciences, Inc. · 2008-12-31 Entia Biosciences, Inc. (edgar:1408299) Net Income: -121135 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -121135 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-10-000228.txt#1156 The citation records this snapshot. The page link may show a newer release later.	−USD 304,784 Exact value Exact value: -304784 USD 2008-01-01 – 2008-12-31: -304784 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Entia Biosciences, Inc. · 2008-12-31 Entia Biosciences, Inc. (edgar:1408299) Operating Cash Flow: -304784 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -304784 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-10-000228.txt#1199 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2008-01-01 – 2008-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Entia Biosciences, Inc. · 2008-12-31 Entia Biosciences, Inc. (edgar:1408299) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-10-000056.txt#3920 The citation records this snapshot. The page link may show a newer release later.	−USD 304,784 Calculation and evidence -304784 − 0 USD Exact free cash flow: -304784 USD 2008-01-01 – 2008-12-31: -304784 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Entia Biosciences, Inc. · 2008-12-31 Entia Biosciences, Inc. (edgar:1408299) Free cash flow: -304784 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -304784 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-10-000228.txt#1199 Input fundies:CapitalExpenditure: 0 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-10-000056.txt#3920 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 926,789 Exact value Exact value: -926789 USD 2009-01-01 – 2009-12-31: -926789 USD Inspect Net Income Open source Share or cite Citation for Net Income · Entia Biosciences, Inc. · 2009-12-31 Entia Biosciences, Inc. (edgar:1408299) Net Income: -926789 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -926789 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-11-000077.txt#55 The citation records this snapshot. The page link may show a newer release later.	−USD 554,658 Exact value Exact value: -554658 USD 2009-01-01 – 2009-12-31: -554658 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Entia Biosciences, Inc. · 2009-12-31 Entia Biosciences, Inc. (edgar:1408299) Operating Cash Flow: -554658 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -554658 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-11-000077.txt#55 The citation records this snapshot. The page link may show a newer release later.	USD 20,712 Exact value Exact value: 20712 USD 2009-01-01 – 2009-12-31: 20712 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Entia Biosciences, Inc. · 2009-12-31 Entia Biosciences, Inc. (edgar:1408299) Capital Expenditure: 20712 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20712 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-11-000077.txt#55 The citation records this snapshot. The page link may show a newer release later.	−USD 575,370 Calculation and evidence -554658 − 20712 USD Exact free cash flow: -575370 USD 2009-01-01 – 2009-12-31: -554658 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 20712 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Entia Biosciences, Inc. · 2009-12-31 Entia Biosciences, Inc. (edgar:1408299) Free cash flow: -575370 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -554658 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-11-000077.txt#55 Input fundies:CapitalExpenditure: 20712 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-11-000077.txt#55 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 1.27 million Exact value Exact value: -1266315 USD 2010-01-01 – 2010-12-31: -1266315 USD Inspect Net Income Open source Share or cite Citation for Net Income · Entia Biosciences, Inc. · 2010-12-31 Entia Biosciences, Inc. (edgar:1408299) Net Income: -1266315 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1266315 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000146970912000060/ergo-20111231.xml#35544 Filing: 000146970912000060 The citation records this snapshot. The page link may show a newer release later.	−USD 522,930 Exact value Exact value: -522930 USD 2010-01-01 – 2010-12-31: -522930 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Entia Biosciences, Inc. · 2010-12-31 Entia Biosciences, Inc. (edgar:1408299) Operating Cash Flow: -522930 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -522930 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000146970912000060/ergo-20111231.xml#38843 Filing: 000146970912000060 The citation records this snapshot. The page link may show a newer release later.	USD 31,807 Exact value Exact value: 31807 USD 2010-01-01 – 2010-12-31: 31807 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Entia Biosciences, Inc. · 2010-12-31 Entia Biosciences, Inc. (edgar:1408299) Capital Expenditure: 31807 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 31807 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-11-000077.txt#55 The citation records this snapshot. The page link may show a newer release later.	−USD 554,737 Calculation and evidence -522930 − 31807 USD Exact free cash flow: -554737 USD 2010-01-01 – 2010-12-31: -522930 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 31807 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Entia Biosciences, Inc. · 2010-12-31 Entia Biosciences, Inc. (edgar:1408299) Free cash flow: -554737 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -522930 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000146970912000060/ergo-20111231.xml#38843 Filing: 000146970912000060 Input fundies:CapitalExpenditure: 31807 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/0001469709-11-000077.txt#55 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 1.73 million Exact value Exact value: -1729103 USD 2011-01-01 – 2011-12-31: -1729103 USD Inspect Net Income Open source Share or cite Citation for Net Income · Entia Biosciences, Inc. · 2011-12-31 Entia Biosciences, Inc. (edgar:1408299) Net Income: -1729103 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1729103 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000146970913000163/ergo-20121231.xml#67136 Filing: 000146970913000163 The citation records this snapshot. The page link may show a newer release later.	−USD 208,744 Exact value Exact value: -208744 USD 2011-01-01 – 2011-12-31: -208744 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Entia Biosciences, Inc. · 2011-12-31 Entia Biosciences, Inc. (edgar:1408299) Operating Cash Flow: -208744 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -208744 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000146970913000163/ergo-20121231.xml#152246 Filing: 000146970913000163 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 1.26 million Exact value Exact value: -1264148 USD 2012-01-01 – 2012-12-31: -1264148 USD Inspect Net Income Open source Share or cite Citation for Net Income · Entia Biosciences, Inc. · 2012-12-31 Entia Biosciences, Inc. (edgar:1408299) Net Income: -1264148 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1264148 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000146970914000106/ergo-20131231.xml#76095 Filing: 000146970914000106 The citation records this snapshot. The page link may show a newer release later.	−USD 314,595 Exact value Exact value: -314595 USD 2012-01-01 – 2012-12-31: -314595 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Entia Biosciences, Inc. · 2012-12-31 Entia Biosciences, Inc. (edgar:1408299) Operating Cash Flow: -314595 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -314595 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000146970914000106/ergo-20131231.xml#222009 Filing: 000146970914000106 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 3.1 million Exact value Exact value: -3104827 USD 2013-01-01 – 2013-12-31: -3104827 USD Inspect Net Income Open source Share or cite Citation for Net Income · Entia Biosciences, Inc. · 2013-12-31 Entia Biosciences, Inc. (edgar:1408299) Net Income: -3104827 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3104827 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518515000663/ergo-20141231.xml#191338 Filing: 000118518515000663 The citation records this snapshot. The page link may show a newer release later.	−USD 766,733 Exact value Exact value: -766733 USD 2013-01-01 – 2013-12-31: -766733 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Entia Biosciences, Inc. · 2013-12-31 Entia Biosciences, Inc. (edgar:1408299) Operating Cash Flow: -766733 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -766733 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518515000663/ergo-20141231.xml#222217 Filing: 000118518515000663 The citation records this snapshot. The page link may show a newer release later.	USD 52,548 Exact value Exact value: 52548 USD 2013-01-01 – 2013-12-31: 52548 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Entia Biosciences, Inc. · 2013-12-31 Entia Biosciences, Inc. (edgar:1408299) Capital Expenditure: 52548 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 52548 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518515000663/ergo-20141231.xml#222578 Filing: 000118518515000663 The citation records this snapshot. The page link may show a newer release later.	−USD 819,281 Calculation and evidence -766733 − 52548 USD Exact free cash flow: -819281 USD 2013-01-01 – 2013-12-31: -766733 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 52548 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Entia Biosciences, Inc. · 2013-12-31 Entia Biosciences, Inc. (edgar:1408299) Free cash flow: -819281 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -766733 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518515000663/ergo-20141231.xml#222217 Filing: 000118518515000663 Input fundies:CapitalExpenditure: 52548 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518515000663/ergo-20141231.xml#222578 Filing: 000118518515000663 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 2.3 million Exact value Exact value: -2296591 USD 2014-01-01 – 2014-12-31: -2296591 USD Inspect Net Income Open source Share or cite Citation for Net Income · Entia Biosciences, Inc. · 2014-12-31 Entia Biosciences, Inc. (edgar:1408299) Net Income: -2296591 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2296591 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518516004208/ergo-20151231.xml#163512 Filing: 000118518516004208 The citation records this snapshot. The page link may show a newer release later.	−USD 680,284 Exact value Exact value: -680284 USD 2014-01-01 – 2014-12-31: -680284 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Entia Biosciences, Inc. · 2014-12-31 Entia Biosciences, Inc. (edgar:1408299) Operating Cash Flow: -680284 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -680284 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518516004208/ergo-20151231.xml#192083 Filing: 000118518516004208 The citation records this snapshot. The page link may show a newer release later.	USD 4,607 Exact value Exact value: 4607 USD 2014-01-01 – 2014-12-31: 4607 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Entia Biosciences, Inc. · 2014-12-31 Entia Biosciences, Inc. (edgar:1408299) Capital Expenditure: 4607 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4607 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518516004208/ergo-20151231.xml#192444 Filing: 000118518516004208 The citation records this snapshot. The page link may show a newer release later.	−USD 684,891 Calculation and evidence -680284 − 4607 USD Exact free cash flow: -684891 USD 2014-01-01 – 2014-12-31: -680284 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 4607 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Entia Biosciences, Inc. · 2014-12-31 Entia Biosciences, Inc. (edgar:1408299) Free cash flow: -684891 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -680284 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518516004208/ergo-20151231.xml#192083 Filing: 000118518516004208 Input fundies:CapitalExpenditure: 4607 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518516004208/ergo-20151231.xml#192444 Filing: 000118518516004208 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 2.26 million Exact value Exact value: -2260050 USD 2015-01-01 – 2015-12-31: -2260050 USD Inspect Net Income Open source Share or cite Citation for Net Income · Entia Biosciences, Inc. · 2015-12-31 Entia Biosciences, Inc. (edgar:1408299) Net Income: -2260050 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2260050 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#157360 Filing: 000118518517001225 The citation records this snapshot. The page link may show a newer release later.	−USD 536,565 Exact value Exact value: -536565 USD 2015-01-01 – 2015-12-31: -536565 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Entia Biosciences, Inc. · 2015-12-31 Entia Biosciences, Inc. (edgar:1408299) Operating Cash Flow: -536565 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -536565 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177262 Filing: 000118518517001225 The citation records this snapshot. The page link may show a newer release later.	USD 8,051 Exact value Exact value: 8051 USD 2015-01-01 – 2015-12-31: 8051 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Entia Biosciences, Inc. · 2015-12-31 Entia Biosciences, Inc. (edgar:1408299) Capital Expenditure: 8051 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8051 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177620 Filing: 000118518517001225 The citation records this snapshot. The page link may show a newer release later.	−USD 544,616 Calculation and evidence -536565 − 8051 USD Exact free cash flow: -544616 USD 2015-01-01 – 2015-12-31: -536565 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 8051 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Entia Biosciences, Inc. · 2015-12-31 Entia Biosciences, Inc. (edgar:1408299) Free cash flow: -544616 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -536565 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177262 Filing: 000118518517001225 Input fundies:CapitalExpenditure: 8051 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177620 Filing: 000118518517001225 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 1.4 million Exact value Exact value: -1395782 USD 2016-01-01 – 2016-12-31: -1395782 USD Inspect Net Income Open source Share or cite Citation for Net Income · Entia Biosciences, Inc. · 2016-12-31 Entia Biosciences, Inc. (edgar:1408299) Net Income: -1395782 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1395782 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#157235 Filing: 000118518517001225 The citation records this snapshot. The page link may show a newer release later.	−USD 715,098 Exact value Exact value: -715098 USD 2016-01-01 – 2016-12-31: -715098 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Entia Biosciences, Inc. · 2016-12-31 Entia Biosciences, Inc. (edgar:1408299) Operating Cash Flow: -715098 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -715098 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177080 Filing: 000118518517001225 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2016-01-01 – 2016-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Entia Biosciences, Inc. · 2016-12-31 Entia Biosciences, Inc. (edgar:1408299) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177444 Filing: 000118518517001225 The citation records this snapshot. The page link may show a newer release later.	−USD 715,098 Calculation and evidence -715098 − 0 USD Exact free cash flow: -715098 USD 2016-01-01 – 2016-12-31: -715098 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Entia Biosciences, Inc. · 2016-12-31 Entia Biosciences, Inc. (edgar:1408299) Free cash flow: -715098 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T20:00:23Z Snapshot: 0e2f329a04969feb9ecef40ab2a4601be15b4f0ab09a848ad60a655e1d385e69 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1408299?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -715098 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177080 Filing: 000118518517001225 Input fundies:CapitalExpenditure: 0 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1408299/000118518517001225/ergo-20161231.xml#177444 Filing: 000118518517001225 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

45 filings · 1,605 latest values · 1,605 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001408299, 1408299, edgar:1408299

Also known as Entia Biosciences, Inc., Generic Marketing Services, Inc., Total Nutraceutical Solutions, Total Nutraceutical Solutions, Inc.

Entia Biosciences, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2016 2016-01-01 – 2016-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation